Telehealth and Telemedicine Market

1.1. Global Market Outlook
1.2. Summary of Statistics
1.3. Key Market Characteristics & Attributes
1.4. Fact.MR Analysis and Recommendations

2.1. Market Coverage
2.2. Market Definition

3.1. Risk Assessment
3.1.1. COVID-19 Crisis and Impact on Telehealth & Telemedicine Demand
3.1.2. COVID-19 Impact Benchmark with Previous Crisis
3.1.3. Impact on Market Value (US$ Mn)
3.1.4. Assessment by Key Countries
3.1.5. Assessment by Key Market Segments
3.1.6. Action Points and Recommendation for Suppliers
3.2. Key Trends Impacting the Market
3.3. Formulation and Product Development Trends

4.1. Telehealth & Telemedicine Market, by Key Countries
4.2. Telehealth & Telemedicine Market Opportunity Assessment (US$ Mn)
4.2.1. Total Available Market
4.2.2. Serviceable Addressable Market
4.2.3. Serviceable Obtainable Market
4.3. Market Scenario Forecast
4.3.1. Demand in optimistic Scenario
4.3.2. Demand in Likely Scenario
4.3.3. Demand in Conservative Scenario
4.4. Investment Feasibility Analysis
4.4.1. Investment in Established Markets
4.4.1.1. In Short Term
4.4.1.2. In Long Term
4.4.2. Investment in Emerging Markets
4.4.2.1. In Short Term
4.4.2.2. In Long Term
4.5. Forecast Factors - Relevance & Impact
4.5.1. Top Companies Historical Growth
4.5.2. Growth in Automation, By Country
4.5.3. Telehealth & Telemedicine Adoption Rate, By Country
4.6. Market Dynamics
4.6.1. Market Driving Factors and Impact Assessment
4.6.2. Prominent Market Challenges and Impact Assessment
4.6.3. Telehealth & Telemedicine Market Opportunities
4.6.4. Prominent Trends in the Global Market & Their Impact Assessment

5.1. Manufacturers’ Focus on Low Penetration High Growth Markets
5.2. Banking on with Segments High Incremental Opportunity
5.3. Peer Benchmarking

6.1. Historical Market Analysis, 2015-2021
6.2. Current and Future Market Projections, 2022-2032
6.3. Y-o-Y Growth Trend Analysis

7.1. Historical Market Value (US$ Mn) Analysis, 2015-2021
7.2. Current and Future Market Value (US$ Mn) Projections, 2022-2032
7.2.1. Y-o-Y Growth Trend Analysis
7.2.2. Absolute $ Opportunity Analysis

8.1. Introduction/Key Findings
8.2. Historical Market Size (US$ Mn) Analysis By Component, 2015-2021
8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Component, 2022-2032
8.3.1. Software & Services
8.3.1.1. Remote Patient Monitoring
8.3.1.2. Real-Time Interaction
8.3.1.3. Store and Forward
8.3.2. Hardware
8.3.2.1. Monitors
8.3.2.2. Medical Peripheral Devices
8.3.2.2.1. Blood Pressure Monitors
8.3.2.2.2. Blood Glucose Meters
8.3.2.2.3. Weight Scales
8.3.2.2.4. Pulse Oximeters
8.3.2.2.5. Peak Flow Meters
8.3.2.2.6. ECG Monitors
8.3.2.2.7. Other Medical Peripheral Devices
8.4. Market Attractiveness Analysis By Component

9.1. Introduction/Key Findings
9.2. Historical Market Size (US$ Mn) Analysis By Mode of Delivery, 2015-2021
9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Mode of Delivery, 2022-2032
9.3.1. Cloud-based
9.3.2. On-premise
9.4. Market Attractiveness Analysis By Mode of Delivery

10.1. Introduction/Key Findings
10.2. Historical Market Size (US$ Mn) Analysis By Application, 2015-2021
10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Application, 2022-2032
10.3.1. Teleconsultation
10.3.2. TeleICU
10.3.3. Telestroke
10.3.4. Teleradiology
10.3.5. Telepsychiatry
10.3.6. Teledermatology
10.3.7. Other Applications
10.4. Market Attractiveness Analysis By Application

11.1. Introduction/Key Findings
11.2. Historical Market Size (US$ Mn) Analysis By End User, 2015-2021
11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End User, 2022-2032
11.3.1. Providers
11.3.2. Payers
11.3.3. Patients
11.3.4. Other End Users
11.4. Market Attractiveness Analysis By End User

12.1. Introduction
12.2. Historical Market Size (US$ Mn) Analysis By Region, 2015-2021
12.3. Current Market Size (US$ Mn) & Analysis and Forecast By Region, 2022-2032
12.3.1. North America
12.3.2. Latin America
12.3.3. Europe
12.3.4. Asia Pacific
12.3.5. Middle East and Africa (MEA)
12.4. Market Attractiveness Analysis By Region

13.1. Introduction
13.2. Pricing Analysis
13.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021
13.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032
13.4.1. By Country
13.4.1.1. U.S.
13.4.1.2. Canada
13.4.1.3. Rest of North America
13.4.2. By Component
13.4.3. By Mode of Delivery
13.4.4. By End User
13.4.5. By Application
13.5. Market Attractiveness Analysis
13.5.1. By Country
13.5.2. By Component
13.5.3. By Mode of Delivery
13.5.4. By End User
13.5.5. By Application

14.1. Introduction
14.2. Pricing Analysis
14.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021
14.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032
14.4.1. By Country
14.4.1.1. Brazil
14.4.1.2. Mexico
14.4.1.3. Rest of Latin America
14.4.2. By Component
14.4.3. By Mode of Delivery
14.4.4. By End User
14.4.5. By Application
14.5. Market Attractiveness Analysis
14.5.1. By Country
14.5.2. By Component
14.5.3. By Mode of Delivery
14.5.4. By End User
14.5.5. By Application

15.1. Introduction
15.2. Pricing Analysis
15.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021
15.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032
15.4.1. By Country
15.4.1.1. Germany
15.4.1.2. France
15.4.1.3. U.K.
15.4.1.4. Italy
15.4.1.5. Benelux
15.4.1.6. Nordic Countries
15.4.1.7. Rest of Europe
15.4.2. By Component
15.4.3. By Mode of Delivery
15.4.4. By End User
15.4.5. By Application
15.5. Market Attractiveness Analysis
15.5.1. By Country
15.5.2. By Component
15.5.3. By Mode of Delivery
15.5.4. By End User
15.5.5. By Application

16.1. Introduction
16.2. Pricing Analysis
16.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021
16.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032
16.4.1. By Country
16.4.1.1. China
16.4.1.2. Japan
16.4.1.3. South Korea
16.4.1.4. Rest of Asia Pacific
16.4.2. By Component
16.4.3. By Mode of Delivery
16.4.4. By End User
16.4.5. By Application
16.5. Market Attractiveness Analysis
16.5.1. By Country
16.5.2. By Component
16.5.3. By Mode of Delivery
16.5.4. By End User
16.5.5. By Application

17.1. Introduction
17.2. Pricing Analysis
17.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021
17.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032
17.4.1. By Country
17.4.1.1. GCC Countries
17.4.1.2. South Africa
17.4.1.3. Turkey
17.4.1.4. Rest of Middle East and Africa
17.4.2. By Component
17.4.3. By Mode of Delivery
17.4.4. By End User
17.4.5. By Application
17.5. Market Attractiveness Analysis
17.5.1. By Country
17.5.2. By Component
17.5.3. By Mode of Delivery
17.5.4. By End User
17.5.5. By Application

18.1. Introduction
18.1.1. Market Value Proportion Analysis, By Key Countries
18.1.2. Global Vs. Country Growth Comparison
18.2. US Telehealth & Telemedicine Market Analysis
18.2.1. Value Proportion Analysis by Market Taxonomy
18.2.2. Value Analysis and Forecast by Market Taxonomy, 2015-2032
18.2.2.1. By Component
18.2.2.2. By Mode of Delivery
18.2.2.3. By End User
18.2.2.4. By Application
18.3. Canada Telehealth & Telemedicine Market Analysis
18.3.1. Value Proportion Analysis by Market Taxonomy
18.3.2. Value Analysis and Forecast by Market Taxonomy, 2015-2032
18.3.2.1. By Component
18.3.2.2. By Mode of Delivery
18.3.2.3. By End User
18.3.2.4. By Application
18.4. Mexico Telehealth & Telemedicine Market Analysis
18.4.1. Value Proportion Analysis by Market Taxonomy
18.4.2. Value Analysis and Forecast by Market Taxonomy, 2015-2032
18.4.2.1. By Component
18.4.2.2. By Mode of Delivery
18.4.2.3. By End User
18.4.2.4. By Application
18.5. Brazil Telehealth & Telemedicine Market Analysis
18.5.1. Value Proportion Analysis by Market Taxonomy
18.5.2. Value Analysis and Forecast by Market Taxonomy, 2015-2032
18.5.2.1. By Component
18.5.2.2. By Mode of Delivery
18.5.2.3. By End User
18.5.2.4. By Application
18.6. Germany Telehealth & Telemedicine Market Analysis
18.6.1. Value Proportion Analysis by Market Taxonomy
18.6.2. Value Analysis and Forecast by Market Taxonomy, 2015-2032
18.6.2.1. By Component
18.6.2.2. By Mode of Delivery
18.6.2.3. By End User
18.6.2.4. By Application
18.7. France Telehealth & Telemedicine Market Analysis
18.7.1. Value Proportion Analysis by Market Taxonomy
18.7.2. Value Analysis and Forecast by Market Taxonomy, 2015-2032
18.7.2.1. By Component
18.7.2.2. By Mode of Delivery
18.7.2.3. By End User
18.7.2.4. By Application
18.8. Italy Telehealth & Telemedicine Market Analysis
18.8.1. Value Proportion Analysis by Market Taxonomy
18.8.2. Value Analysis and Forecast by Market Taxonomy, 2015-2032
18.8.2.1. By Component
18.8.2.2. By Mode of Delivery
18.8.2.3. By End User
18.8.2.4. By Application
18.9. BENELUX Telehealth & Telemedicine Market Analysis
18.9.1. Value Proportion Analysis by Market Taxonomy
18.9.2. Value Analysis and Forecast by Market Taxonomy, 2015-2032
18.9.2.1. By Component
18.9.2.2. By Mode of Delivery
18.9.2.3. By End User
18.9.2.4. By Application
18.10. UK Telehealth & Telemedicine Market Analysis
18.10.1. Value Proportion Analysis by Market Taxonomy
18.10.2. Value Analysis and Forecast by Market Taxonomy, 2015-2032
18.10.2.1. By Component
18.10.2.2. By Mode of Delivery
18.10.2.3. By End User
18.10.2.4. By Application
18.11. Nordic Countries Telehealth & Telemedicine Market Analysis
18.11.1. Value Proportion Analysis by Market Taxonomy
18.11.2. Value Analysis and Forecast by Market Taxonomy, 2015-2032
18.11.2.1. By Component
18.11.2.2. By Mode of Delivery
18.11.2.3. By End User
18.11.2.4. By Application
18.12. China Telehealth & Telemedicine Market Analysis
18.12.1. Value Proportion Analysis by Market Taxonomy
18.12.2. Value Analysis and Forecast by Market Taxonomy, 2015-2032
18.12.2.1. By Component
18.12.2.2. By Mode of Delivery
18.12.2.3. By End User
18.12.2.4. By Application
18.13. Japan Telehealth & Telemedicine Market Analysis
18.13.1. Value Proportion Analysis by Market Taxonomy
18.13.2. Value Analysis and Forecast by Market Taxonomy, 2015-2032
18.13.2.1. By Component
18.13.2.2. By Mode of Delivery
18.13.2.3. By End User
18.13.2.4. By Application
18.14. South Korea Telehealth & Telemedicine Market Analysis
18.14.1. Value Proportion Analysis by Market Taxonomy
18.14.2. Value Analysis and Forecast by Market Taxonomy, 2015-2032
18.14.2.1. By Component
18.14.2.2. By Mode of Delivery
18.14.2.3. By End User
18.14.2.4. By Application
18.15. GCC Countries Telehealth & Telemedicine Market Analysis
18.15.1. Value Proportion Analysis by Market Taxonomy
18.15.2. Value Analysis and Forecast by Market Taxonomy, 2015-2032
18.15.2.1. By Component
18.15.2.2. By Mode of Delivery
18.15.2.3. By End User
18.15.2.4. By Application
18.16. South Africa Telehealth & Telemedicine Market Analysis
18.16.1. Value Proportion Analysis by Market Taxonomy
18.16.2. Value Analysis and Forecast by Market Taxonomy, 2015-2032
18.16.2.1. By Component
18.16.2.2. By Mode of Delivery
18.16.2.3. By End User
18.16.2.4. By Application
18.17. Turkey Telehealth & Telemedicine Market Analysis
18.17.1. Value Proportion Analysis by Market Taxonomy
18.17.2. Value Analysis and Forecast by Market Taxonomy, 2015-2032
18.17.2.1. By Component
18.17.2.2. By Mode of Delivery
18.17.2.3. By End User
18.17.2.4. By Application
18.17.3. Competition Landscape and Player Concentration in the Country

19.1. Market Analysis by Tier of Companies
19.2. Market Concentration
19.3. Market Share Analysis of Top Players
19.4. Market Presence Analysis
19.4.1. By Regional footprint of Players
19.4.2. Product footprint by Players

20.1. Competition Dashboard
20.2. Competition Benchmarking
20.3. Competition Deep Dive
20.3.1. KONINKLIJKE PHILIPS
20.3.1.1. Overview
20.3.1.2. Product Portfolio
20.3.1.3. Sales Footprint
20.3.1.4. Strategy Overview
20.3.2. MEDTRONIC
20.3.2.1. Overview
20.3.2.2. Product Portfolio
20.3.2.3. Sales Footprint
20.3.2.4. Strategy Overview
20.3.3. GE HEALTHCARE
20.3.3.1. Overview
20.3.3.2. Product Portfolio
20.3.3.3. Sales Footprint
20.3.3.4. Strategy Overview
20.3.4. CERNER CORPORATION
20.3.4.1. Overview
20.3.4.2. Product Portfolio
20.3.4.3. Sales Footprint
20.3.4.4. Strategy Overview
20.3.5. SIEMENS HEALTHINEERS AG
20.3.5.1. Overview
20.3.5.2. Product Portfolio
20.3.5.3. Sales Footprint
20.3.5.4. Strategy Overview
20.3.6. CISCO SYSTEMS
20.3.6.1. Overview
20.3.6.2. Product Portfolio
20.3.6.3. Sales Footprint
20.3.6.4. Strategy Overview
20.3.7. ASAHI KASEI CORPORATION
20.3.7.1. Overview
20.3.7.2. Product Portfolio
20.3.7.3. Sales Footprint
20.3.7.4. Strategy Overview
20.3.8. IRON BOW TECHNOLOGIES
20.3.8.1. Overview
20.3.8.2. Product Portfolio
20.3.8.3. Sales Footprint
20.3.8.4. Strategy Overview
20.3.9. AMERICAN WELL
20.3.9.1. Overview
20.3.9.2. Product Portfolio
20.3.9.3. Sales Footprint
20.3.9.4. Strategy Overview
20.3.10. TELADOC HEALTH
20.3.10.1. Overview
20.3.10.2. Product Portfolio
20.3.10.3. Sales Footprint
20.3.10.4. Strategy Overview